Nick Abbott

Stock Analyst at Wells Fargo

(0.04)
# 4,089
Out of 4,789 analysts
6
Total ratings
20%
Success rate
-36.09%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Nick Abbott

Zymeworks
Oct 4, 2022
Assumes: Overweight
Price Target: $45$9
Current: $11.62
Upside: -22.55%
Alaunos Therapeutics
Oct 4, 2022
Assumes: Overweight
Price Target: $450
Current: $2.16
Upside: +20,733.33%
Adaptimmune Therapeutics
Oct 4, 2022
Maintains: Equal-Weight
Price Target: $7$1.5
Current: $0.25
Upside: +500.00%
Cellectis
Jan 6, 2022
Downgrades: Equal-Weight
Price Target: $16
Current: $1.32
Upside: +1,112.12%
Affimed
Mar 24, 2021
Maintains: Overweight
Price Target: $100$150
Current: $0.71
Upside: +21,029.74%